CRWV vs UNH: Which Is the Better Buy?
Side-by-side comparison of CoreWeave, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
CoreWeave, Inc. · Technology
$89.89
+24.6% upside to fair value
Med Conviction
Grade C+
VS
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWV |
UNH |
| Current Price |
$89.89 |
$423.38 |
| Fair Value Estimate |
$112.00 |
$613.90 |
| Upside to Fair Value |
+24.6%
|
+45.0%
|
| Market Cap |
$49.0B |
$384.5B |
| Forward P/E |
—
|
27.2x
|
| EV / EBITDA |
26.6x
|
13.8x
|
| Price / Sales |
7.9x
|
0.8x
|
| Price / FCF |
—
|
19.6x
|
| Revenue Growth YoY |
+111.6%
|
+0.4%
|
| Gross Margin |
69.4%
|
18.8%
|
| Operating Margin |
-2.6%
|
4.2%
|
| Return on Equity |
-33.5%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-21.6%
|
5.12%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
CoreWeave is the leading neocloud, a GPU-specialized cloud infrastructure provider built to serve the compute-hungry demands of generative AI training and inference. Since its March 2025 IPO, revenue has scaled roughly 112% year over year to $2.08 billion in the first quarter of 2026, backed by a $99.4 billion contracted revenue backlog and marquee agreements with Microsoft, OpenAI, Meta, Anthrop…
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
| Metric |
CRWV |
UNH |
| Zone Low |
$84.00 |
$460.42 |
| Zone High |
$95.00 |
$521.81 |
| In Buy Zone? |
Yes
|
Yes
|